Compass Therapeutics Inc.
NASDAQ:CMPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
M
|
Montauk Metals Inc
XTSX:MTK
|
CA |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
P
|
President Bakery PCL
SET:PB
|
TH |
|
Celanese Corp
NYSE:CE
|
US |
|
Valuence Merger Corp I
NASDAQ:VMCA
|
US |
|
E
|
eBay Inc
XMUN:EBA
|
US |
|
C
|
CG Oncology Inc
NASDAQ:CGON
|
US |
|
Energia Innovacion y Desarrollo Fotovoltaico SA
MAD:EIDF
|
ES |
Wall St Price Targets
CMPX Price Targets Summary
Compass Therapeutics Inc.
According to Wall Street analysts, the average 1-year price target for CMPX is 9.1 USD with a low forecast of 5.05 USD and a high forecast of 25.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CMPX's stock price target?
Price Target
9.1
USD
According to Wall Street analysts, the average 1-year price target for CMPX is 9.1 USD with a low forecast of 5.05 USD and a high forecast of 25.2 USD.